Brainsway Stock Market Value
| BRSYF Stock | USD 8.53 0.00 0.00% |
| Symbol | BrainsWay |
BrainsWay 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to BrainsWay's pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of BrainsWay.
| 10/02/2023 |
| 12/25/2024 |
If you would invest 0.00 in BrainsWay on October 2, 2023 and sell it all today you would earn a total of 0.00 from holding BrainsWay or generate 0.0% return on investment in BrainsWay over 450 days. BrainsWay is related to or competes with Bone Biologics, BICO Group, Aurora Spine, and Tenon Medical. Brainsway Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United Stat... More
BrainsWay Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure BrainsWay's pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess BrainsWay upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | 0.121 | |||
| Maximum Drawdown | 170.79 |
BrainsWay Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for BrainsWay's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as BrainsWay's standard deviation. In reality, there are many statistical measures that can use BrainsWay historical prices to predict the future BrainsWay's volatility.| Risk Adjusted Performance | 0.108 | |||
| Jensen Alpha | 2.66 | |||
| Total Risk Alpha | 1.66 | |||
| Treynor Ratio | (1.07) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of BrainsWay's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
BrainsWay Backtested Returns
BrainsWay is dangerous given 3 months investment horizon. BrainsWay secures Sharpe Ratio (or Efficiency) of 0.13, which signifies that the company had a 0.13% return per unit of standard deviation over the last 3 months. We have analyzed and interpolated sixteen different technical indicators, which can help you to evaluate if expected returns of 2.71% are justified by taking the suggested risk. Use BrainsWay mean deviation of 5.1, and Risk Adjusted Performance of 0.108 to evaluate company specific risk that cannot be diversified away. BrainsWay holds a performance score of 9 on a scale of zero to a hundred. The firm shows a Beta (market volatility) of -2.4, which signifies a somewhat significant risk relative to the market. As returns on the market increase, returns on owning BrainsWay are expected to decrease by larger amounts. On the other hand, during market turmoil, BrainsWay is expected to outperform it. Use BrainsWay risk adjusted performance, variance, as well as the relationship between the Variance and kurtosis , to analyze future returns on BrainsWay.
Auto-correlation | 0.58 |
Modest predictability
BrainsWay has modest predictability. Overlapping area represents the amount of predictability between BrainsWay time series from 2nd of October 2023 to 14th of May 2024 and 14th of May 2024 to 25th of December 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of BrainsWay price movement. The serial correlation of 0.58 indicates that roughly 58.0% of current BrainsWay price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.58 | |
| Spearman Rank Test | 0.45 | |
| Residual Average | 0.0 | |
| Price Variance | 2.95 |
BrainsWay lagged returns against current returns
Autocorrelation, which is BrainsWay pink sheet's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting BrainsWay's pink sheet expected returns. We can calculate the autocorrelation of BrainsWay returns to help us make a trade decision. For example, suppose you find that BrainsWay has exhibited high autocorrelation historically, and you observe that the pink sheet is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
BrainsWay regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If BrainsWay pink sheet is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if BrainsWay pink sheet is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in BrainsWay pink sheet over time.
Current vs Lagged Prices |
| Timeline |
BrainsWay Lagged Returns
When evaluating BrainsWay's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of BrainsWay pink sheet have on its future price. BrainsWay autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, BrainsWay autocorrelation shows the relationship between BrainsWay pink sheet current value and its past values and can show if there is a momentum factor associated with investing in BrainsWay.
Regressed Prices |
| Timeline |
Currently Active Assets on Macroaxis
Additional Information and Resources on Investing in BrainsWay Pink Sheet
When determining whether BrainsWay offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of BrainsWay's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Brainsway Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Brainsway Stock:Check out BrainsWay Correlation, BrainsWay Volatility and BrainsWay Alpha and Beta module to complement your research on BrainsWay. For more detail on how to invest in BrainsWay Pink Sheet please use our How to Invest in BrainsWay guide.You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.
BrainsWay technical pink sheet analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, pink sheet market cycles, or different charting patterns.